165 related articles for article (PubMed ID: 34893976)
1. Molecular structure, expression, and the emerging role of Siglec-15 in skeletal biology and cancer.
Rashid S; Song D; Yuan J; Mullin BH; Xu J
J Cell Physiol; 2022 Mar; 237(3):1711-1719. PubMed ID: 34893976
[TBL] [Abstract][Full Text] [Related]
2. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
3. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
4. Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma.
Chen Q; Chen B; Wang C; Hu L; Wu Q; Zhu Y; Zhang Q
Front Immunol; 2023; 14():1159085. PubMed ID: 37234161
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis.
Shimizu T; Takahata M; Kameda Y; Endo T; Hamano H; Hiratsuka S; Ota M; Iwasaki N
Bone; 2015 Oct; 79():65-70. PubMed ID: 26027508
[TBL] [Abstract][Full Text] [Related]
6. Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12).
Ishida-Kitagawa N; Tanaka K; Bao X; Kimura T; Miura T; Kitaoka Y; Hayashi K; Sato M; Maruoka M; Ogawa T; Miyoshi J; Takeya T
J Biol Chem; 2012 May; 287(21):17493-17502. PubMed ID: 22451653
[TBL] [Abstract][Full Text] [Related]
7. Siglec-15: an immune system Siglec conserved throughout vertebrate evolution.
Angata T; Tabuchi Y; Nakamura K; Nakamura M
Glycobiology; 2007 Aug; 17(8):838-46. PubMed ID: 17483134
[TBL] [Abstract][Full Text] [Related]
8. Siglec Signaling in the Tumor Microenvironment.
van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():790317. PubMed ID: 34966391
[TBL] [Abstract][Full Text] [Related]
9. The diverse functions of Siglec-15 in bone remodeling and antitumor responses.
Kang FB; Chen W; Wang L; Zhang YZ
Pharmacol Res; 2020 May; 155():104728. PubMed ID: 32112821
[TBL] [Abstract][Full Text] [Related]
10. Siglec-15 as multifunctional molecule involved in osteoclast differentiation, cancer immunity and microbial infection.
Huang R; Zheng J; Shao Y; Zhu L; Yang T
Prog Biophys Mol Biol; 2023 Jan; 177():34-41. PubMed ID: 36265694
[TBL] [Abstract][Full Text] [Related]
11. Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma.
Huang Z; Guo Y; Li B; Shen M; Yi Y; Li L; Zhao X; Yang L
Cancer Gene Ther; 2024 Mar; 31(3):427-438. PubMed ID: 38072971
[TBL] [Abstract][Full Text] [Related]
12. Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice.
Hiruma Y; Tsuda E; Maeda N; Okada A; Kabasawa N; Miyamoto M; Hattori H; Fukuda C
Bone; 2013 Mar; 53(1):87-93. PubMed ID: 23238125
[TBL] [Abstract][Full Text] [Related]
13. Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy.
Sun J; Lu Q; Sanmamed MF; Wang J
Clin Cancer Res; 2021 Feb; 27(3):680-688. PubMed ID: 32958700
[TBL] [Abstract][Full Text] [Related]
14. Siglecs that Associate with DAP12.
Angata T
Adv Exp Med Biol; 2020; 1204():215-230. PubMed ID: 32152949
[TBL] [Abstract][Full Text] [Related]
15. Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption.
Stuible M; Moraitis A; Fortin A; Saragosa S; Kalbakji A; Filion M; Tremblay GB
J Biol Chem; 2014 Mar; 289(10):6498-6512. PubMed ID: 24446437
[TBL] [Abstract][Full Text] [Related]
16. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.
Takamiya R; Ohtsubo K; Takamatsu S; Taniguchi N; Angata T
Glycobiology; 2013 Feb; 23(2):178-87. PubMed ID: 23035012
[TBL] [Abstract][Full Text] [Related]
17. The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption.
Andes FT; Adam S; Hahn M; Aust O; Frey S; Grueneboom A; Nitschke L; Schett G; Steffen U
Bone; 2021 Feb; 143():115665. PubMed ID: 33007530
[TBL] [Abstract][Full Text] [Related]
18. Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway.
Li H; Zhu R; Liu X; Zhao K; Hong D
Oxid Med Cell Longev; 2022; 2022():3341038. PubMed ID: 36105484
[TBL] [Abstract][Full Text] [Related]
19. Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases.
Angata T
J Biomed Sci; 2020 Jan; 27(1):10. PubMed ID: 31900164
[TBL] [Abstract][Full Text] [Related]
20. Siglec-15 on Osteoclasts Is Crucial for Bone Erosion in Serum-Transfer Arthritis.
Korn MA; Schmitt H; Angermüller S; Chambers D; Seeling M; Lux UT; Brey S; Royzman D; Brückner C; Popp V; Percivalle E; Bäuerle T; Zinser E; Winkler TH; Steinkasserer A; Nimmerjahn F; Nitschke L
J Immunol; 2020 Nov; 205(10):2595-2605. PubMed ID: 33020147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
